lobbying_activities: 1405110

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1405110	0b38c9dc-2823-4137-9aa0-2e81237feec1	Q2	MASSACHUSETTS MEDICAL SOCIETY	23975	MASSACHUSETTS MEDICAL SOCIETY	2013	second_quarter	MMM	Medicare Physician Payment Reform Proposals. House Energy and Commerce Committee, Ways and Means Draft, Senate Finance - QuestionsHR 574 - Medicare Physician Payment Innovation Act Sequestration - Medicare Physician Payment Cuts - no specific bill S. Con. Res. 8, H Con Res 25 - Medicare & Medicaid reforms including, Medicare physician payment reform, beneficiary changes, increased Medicaid Payments to Primary Care providers, Graduate Medical Education Cuts HR 351, S.351 - Protecting Seniors Access to Medication Act of 2013 - repeals IPAB HR 1827 - Pediatric Subspecialty and Mental Health Workplace Reauthorization Act S. 972, HR 1701 "Cutting Costly Codes Act of 2013" - Changes to ICD10 HR 1310, S. 236 - Medicare Patient Empowerment Act Drug Diversion issues including, reauthorization of the NASPER, appropriations for the Substance Abuse & Mental Health Services Administration, funding for state based grants for infrastructure & funding for GME on drug diversion issues Medicare ACOs - no specific bill Medical Liability Reform Funding for pilot grant for Disclosure, Apology & Offer laws - no specific bill Meaningful Use Regulations Stage II Sunshine Act Regulations impact on scientific peer reviewed medical journals - no specific bill	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE		60000	0	0	2013-07-11T14:58:10-04:00